| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Stuelpnagel John R is a Director at 10x Genomics, Inc.. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $7.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | TXG 10x Genomics, Inc. | Director | Sell | 10,000 | $54.89 | $548,894.00 | -2.9% | -4.5% | -60.9% | |
| Dec 30, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $150.92 | $754,589.62 | -0.7% | -50.5% | -75.8% | |
| Dec 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $151.16 | $755,819.93 | -0.3% | -43.9% | -72.6% | |
| Nov 16, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $158.83 | $794,166.29 | -0.4% | -44.3% | -75.3% | |
| Nov 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $163.51 | $817,567.21 | -0.2% | -41.2% | -82.8% | |
| Oct 18, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $150.67 | $753,342.87 | -0.5% | -39.8% | -82.6% | |
| Oct 7, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $150.18 | $750,899.00 | -1.3% | -14.8% | -81.5% | |
| Sep 16, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $156.33 | $781,668.11 | -0.3% | -12.2% | -80.8% | |
| Sep 1, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $177.48 | $887,411.35 | -0.3% | -14.9% | -82.0% | |
| Aug 16, 2021 | TXG 10x Genomics, Inc. | Director | Sell | 5,000 | $159.56 | $797,824.45 | -0.3% | -1.3% | -71.0% |